Immunotherapy in head and neck squamous cell carcinoma and rare head and neck malignancies

The dismal prognosis of recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC) prompted recent advances in the field of therapeutic approaches beyond cytotoxic cancer therapy. In recent years, the deeper and increasing knowledge on the genomic landscape and the upcoming new data on...

Descripción completa

Detalles Bibliográficos
Autores principales: Cavalieri, Stefano, Filippini, Daria Maria, Ottini, Arianna, Bergamini, Cristiana, Resteghini, Carlo, Colombo, Elena, Lombardo, Roberta, Nuzzolese, Imperia, Alfieri, Salvatore, Licitra, Lisa, Locati, Laura D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Open Exploration 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9400733/
https://www.ncbi.nlm.nih.gov/pubmed/36046116
http://dx.doi.org/10.37349/etat.2021.00062

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9400733/
https://www.ncbi.nlm.nih.gov/pubmed/36046116
http://dx.doi.org/10.37349/etat.2021.00062

Ejemplares similares